论文部分内容阅读
目的探讨黄芪注射液联合参麦注射液治疗小儿病毒性心肌炎的临床疗效。方法将68例病毒性心肌炎患儿随机分为对照组和观察组各34例,对照组给予常规治疗,观察组在对照组基础上给予黄芪注射液、参麦注射液治疗。比较两组的疗效。结果观察组治疗总有效率94.12%,高于对照组的73.53,差异有统计学意义(P<0.05)。观察组心电图改善总有效率91.18%,高于对照组的64.71%,差异有统计学意义(P<0.05)。结论黄芪注射液联合参麦注射液治疗小儿病毒性心肌炎可提高临床疗效,缩短病程,值得临床推广。
Objective To investigate the clinical efficacy of Astragalus injection combined with Shenmai injection in the treatment of viral myocarditis in children. Methods Sixty-eight children with viral myocarditis were randomly divided into control group and observation group, with 34 cases in each group. The control group was given routine treatment. The observation group was given astragalus injection and Shenmai injection on the basis of the control group. Compare the curative effect of two groups. Results The total effective rate of the observation group was 94.12%, which was higher than that of the control group (73.53), the difference was statistically significant (P <0.05). In the observation group, the total effective rate of electrocardiogram improvement was 91.18%, which was higher than that of the control group (64.71%), the difference was statistically significant (P <0.05). Conclusion Astragalus injection combined with Shenmai injection in children with viral myocarditis can improve clinical efficacy and shorten the course of disease, is worth clinical promotion.